Dyne Therapeutics suspends ATM offering; had raised $92.2M from prior sales

Dyne Therapeutics, Inc.

Company notified Jefferies it suspended and terminated the ATM prospectus dated Nov 17, 2021.
Sales agreement remains in effect; no further sales until a new prospectus is filed.
As of Jan 4, 2024, sold 7,943,148 shares for aggregate gross proceeds of $92.2 million.

item 8.01

Dyne Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-002542

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.